平特五不中

Dr. Melichar pursued her doctoral studies at the University of Massachusetts Medical School focusing on the molecular mechanisms influencing T cell fate decisions. She then moved to the west coast and began a postdoctoral fellowship at the University of California, Berkeley, where she developed novel platforms to study the development of both murine and human T cells in situ. In 2014, Dr. Melichar established her independent research group at the Maisonneuve-Rosemont Hospital Research Center affiliated with the University of Montreal. After almost 10 years in this position, Dr. Melichar was recruited to the Goodman Cancer Institute at 平特五不中 where her laboratory continues to study the cellular and molecular mechanisms that regulate the development and function of T cells using insights from these studies to improve the efficacy of cellular therapies.